What makes an early-stage company stand out to investors, and what can stop a promising startup from being investment-ready? Join Cara Schoettes of Sims Venture Capital and Isaiah Reeves of Solas BioVentures for an investor’s perspective on what matters when evaluating early-stage companies. This session will explore the key factors investors consider, common gaps and red flags they encounter, and how founders can better position their companies for investment. Attendees will leave with practical insights they can use to assess their own readiness and strengthen their approach to future investor conversations.
This session will be hosted in person and virtually. A Zoom link will be send in your confirmation email.
Immediately afterward, Life Science TN will host a Beer & Biotech at Yee-Haw Brewing Company. You can sign up for that here.
